Most Read Articles

Viewssort iconArticle
4531R. Scott Kennedy Awarded the 2008 El-Hibri Peace Education Prize
2468Former Dhhs Secretary, Dr. Louis W. Sullivan, Joins Board Of Directors Of Emergent Biosolutions
2450Fuad El-Hibri Ernst & Young Entrepreneur of the Year
1808Bad News Clouds Two Bio Defense Stocks
573Emergent Biosolutions Announces Dr. Stephen Lockhart Joins Company To Lead Commercial Product Development Subsidiary
308Oxford-Emergent Tuberculosis Consortium Signs Commercial License Agreement with Vivalis to Explore Production Of MVA85A TB Vacci
235Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young
226Emergent BioSolutions Announces That BioThrax (Anthrax Vaccine Adsorbed) Receives Market Authorization in India
218Nominations Being Accepted Now for 2010 El-Hibri Peace Education Prize
217Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary Assembly
204New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South Africa
197EMERGENT BIOSOLUTIONS ANNOUNCES EXPANSION OF BOARD OF DIRECTORS AND APPOINTMENT OF DR. SUE BAILEY TO THE COMPANY’S BOARD OF DIRE
196Washington Launched Me, But I am Proud to be a Lebanese Dreaming of New Technology - Al Anwar
192Fuad El-Hibri on Twine
191Emergent BioSolutions hands out bonuses
190Emergent Biosolutions Delivers Over 3 Million Doses Of Biothrax® To U.S. Department Of Health And Human Services For Strategic N
182October 9, 2008 - Farr Honors Former Santa Cruz Mayor
181Emergent Biosolutions Announces Management Changes
175Lebanese CEO Sees Opportunity in Current Crisis
170Emergent BioSolutions Buys Rival Vaccine for $2 Million
166 Emergent BioSolutions reacts to BARDA's Request for Proposal cancellation
159Fuad El-Hibri Official Bio Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding Int
159Emergent Biosolutions Receives Development Contract From Niaid/Barda To Fund Continued Development Of Anthrax Therapeutic
149Emergrnt Biosultions on Answers.com
149Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore
141EMERGENT BIOSOLUTIONS ANNOUNCES MANAGEMENT CHANGES
130Emergent Biosolutions Acquires Monoclonal Anthrax Product Candidate
124EMERGENT BIOSOLUTIONS ANTICIPATES 2ND QUARTER BIOTHRAX REVENUES OF APPROXIMATELY $20 MILLION BASED ON ACCELERATED DELIVERY TO DE
124Board expands with Election of Fuad El-Hibri
120Maker of anthrax vaccine discusses challenges of marketing overseas
116Joe M. Allbaugh, Former Fema Director, Joins Emergent Biosolutions’ Board Of Directors
112Emergent BioSolutions Inc. (EBS) CEO & Chairman, 10% Owner Fuad El-hibri sells 15,000 Shares
112Fuad El-Hibri on Webbiographies
109Fued El-Hibri Profile on Forbes
108Fuad El-Hibri and Healthcare Reform
108Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland
104Emergent Biosolutions Expands Presence In Germany
103Emergent BioSolutions to Participate in June 2010 Investor Conferences
101Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript
101Fuad El-Hibri on Businessweek
100U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES REMAINS COMMITTED TO PROCUREMENT OF BIOTHRAX® UNDER CURRENT CONTRACT
99Emergent looks to buy Maryland lab
99Jerome M. Hauer Named To Board Of Directors Of Emergent Biosolutions
99The El-Hibri Foundation Launches Website
98Fuad El-Hibri on Wikipedia
98Ernst & Young’s Entrepreneur of the Year Fuad El-Hibri
97Nomination Deadline Approaching for 2010 El-Hibri Peace Education Prize
97STATEMENT BY FUAD EL-HIBRI, EMERGENT BIOSOLUTIONS CHAIRMAN AND CHIEF EXECUTIVE OFFICER, ON THE PASSING OF ADMIRAL WILLIAM CROWE,
95EMERGENT BIOSOLUTIONS’ TYPHOID VACCINE CANDIDATE ACHIEVES ENDPOINTS IN PHASE II CLINICAL STUDY
95Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax
95Emergent biosolutions announces that department OF HEALTH AND HUMAN SERVICES AND DEPARTMENT OF DEFENSE ISSUED NOTICES OF INTENT
92Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Winner in
91Emergent BioSolutions moves forward with typhoid vaccine
90About Fuad El-Hibri on Atlanta Business Chronicle
89U.S. Government To Purchase Additional 14.5 Million Doses Of Biothrax® Under New Contract Valued At Up To $404 Million
88Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility
88Fuad El-Hibri is a Washington-Area Success Story
87EMERGENT BIOSOLUTIONS SIGNS $448 MILLION THREE YEAR CONTRACT WITH DEPARTMENT OF HEALTH AND HUMAN SERVICES
86<a href="http://www.muckety.com/Fuad-El-Hibri/8838.muckety">Fuad El-
82Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst &amp; Young Entrepreneur of the Year 2009 Award Finalist
82EMERGENT BIOSOLUTIONS ANNOUNCES THE APPOINTMENT OF DENISE LANDRY AS SENIOR VICE PRESIDENT, QUALITY
82Rene Moawad Foundation (RMF) USA Holds 14th Annual Washington Gala Dinner
81Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians
81Fuad El-Hibri on Social Networks
79Digg Fuad El-Hibri
79Fuad El-Hibri’s Linkedin Profile
77Fuad El-Hibri Earnings Call
75Fuad El-Hibri El-Hibri Peace Education Prize
74Fuad El-Hibri Profiles
73Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments
71Fuad El-Hibri on Corridor Inc.
70Emergent Revises Upward 2010 Financial Forecast
69Emergent Biosolutions El-Hibri
66Emergent BioSolutions and Ninebio Sdn. Bhd. AnnounceJoint Venture in Malaysia.
65EMERGENT BIOSOLUTIONS ANNOUNCES RESULTS FROM ANNUAL MEETING OF STOCKHOLDERS
63Peace Prize awarded to Center for Nonviolence’s Kennedy
59Emergent BioSolutions To Acquire Protein Sciences’ Phase III Recombinant Flu Vaccine Candidate, FluBlok(R), And Related Novel Pl
54EMERGENT BIOSOLUTIONS INC Profile on AOL
42Emergent BioSolutions to Acquire Trubion Pharmaceuticals
31Colman McCarthy to Receive 2010 EL-HIBRI Peace Education Prize
13Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars